Trial of Temozolomide, Bevacizumab Plus Bortezomib for Recurrent Glioblastoma Multiforme

This study has been completed.
Sponsor:
Collaborators:
Schering-Plough
Genentech, Inc.
Millennium Pharmaceuticals, Inc.
Information provided by (Responsible Party):
Jeffrey James Olson, Emory University
ClinicalTrials.gov Identifier:
NCT01435395
First received: September 14, 2011
Last updated: April 25, 2016
Last verified: April 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: April 2016
  Primary Completion Date: April 2016 (Final data collection date for primary outcome measure)